203 results · 21ms · Sources: EU EUDAMED, US FDA

NAVITRACK SYSTEM: TOTAL HIP REPLACEMENT CT-FREE CUP, MODEL 900.204

FDA 510(k)
FDA Class 2 ·Neurology

Rosa Knee System

FDA 510(k)
FDA Class 2 ·Neurology

NAVITRACK SYSTEM - OS UNICONDYLAR KNEE UNIVERSAL, MODEL# PRO-06003

FDA 510(k)
FDA Class 2 ·Neurology

OptiVu ROSA MxR

FDA 510(k)
FDA Class 2 ·Radiology

NAVITRACK SYSTEM- PARTIAL HIP RESURFACING UNIVERSAL

FDA 510(k)
FDA Class 2 ·Neurology

ONE Planner Hip

FDA 510(k)
FDA Class 2 ·Radiology

Signature ONE System

FDA 510(k)
FDA Class 2 ·Orthopedic

ROSA Hip System

FDA 510(k)
FDA Class 2 ·Radiology

ROSA® Shoulder System

FDA 510(k)
FDA Class 2 ·Neurology

CAS FIXATION PIN 3.2 DIA X 180 MM STR, CAS FIXATON PIN 3.2 DIA X 80 MM STR, CAS FIXATON PIN 3.2 DIA X 150 MM

FDA 510(k)
FDA Class 2 ·Neurology

ROSA® Knee System

FDA 510(k)
FDA Class 2 ·Neurology

LEE ALLEN'S UNIVERSAL MOTILITY IMPLANT

FDA 510(k)
FDA Class 2 ·Ophthalmic

NAVITRACK SYSTEM-OS KNEE UNIVERSAL, MODEL PRO-05002

FDA 510(k)
FDA Class 2 ·Neurology

ROSA Knee System

FDA 510(k)
FDA Class 2 ·Neurology

IASSIST KNEE SYSTEM

FDA 510(k)
FDA Class 2 ·Neurology

NAVITRACK SYSTEM-OPTICAL TKR CT-LESS, MODEL 900.120

FDA 510(k)
FDA Class 2 ·Neurology

EPTFE SHEET COVERING FOR OCULAR IMPLANT

FDA 510(k)
FDA Class 2 ·Ophthalmic

ROSA® Knee System

FDA 510(k)
FDA Class 2 ·Neurology

Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment

FDA classification
FDA Class 2 ·Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment

Normalizing Quantitative Electroencephalograph Software

FDA classification
FDA Class 2 ·Normalizing Quantitative Electroencephalograph Software